Cytokinetics Names Robert Califf, M.D., to Board of Directors

NEXT STORY
Status asthmaticus risk upped fourfold with IV labetalol for preeclampsia
PREV STORY
Study: Half of doctors sued by age 55
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

author_avatar
NASDAQ Market News

Single-Inhaler Extrafine Triple Therapy of Inhaled Corticosteroid, Long-Acting B2-Agonist and Long-Acting Muscarinic Antagonist Therapy Improves Lung Function and Reduces Asthma Exacerbations(1)

author_avatar
NASDAQ Market News

Cybrexa Therapeutics Closes $25 Million Series B Financing

author_avatar
NASDAQ Market News